Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models

syn27761862

Created By Demo User avu

dataType: drugScreen
studyName: Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models
dataStatus: Available
initiative: Drug Discovery Initiative Registered Reports
studyLeads: Vijaya Ramesh Lei Xu Roberta Beauchamp
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 2
institutions: Massachusetts General Hospital
fundingAgency: CTF
manifestation: Schwannoma Meningioma
relatedStudies: syn26383473 syn51907739 syn35632706 syn2343195
studyFileviewId: syn27761911
syn27761877
syn27761881
syn27761911
syn27761883

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models

syn27761862

Drop files to upload

Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models page is loading…